MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jha2.70233

Медицинская библиотека · EJHaem · 2026

Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.

Coste A, Godet S, Manier S, Eveillard J R, Croizier C, Mariette C, Breal C, Manjra H, Touzeau C, Mohty M, Belkhir R, Bobin A, Lévêque A, Cherel B, Montes L, Orsini-Piocelle F, Frenzel L, Robu D, Chalayer E, Harel S, Vincent L, Bauschert L, Dony A, Tabrizi R, Moreau P, Hulin C, Perrot A

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Real-world data on teclistamab in relapsed or refractory multiple myeloma (R/R MM), particularly in elderly patients, remain limited.

METHODS

We analysed efficacy and safety outcomes in patients ≥ 75 years from the French RetrosTECtive cohort. Among 303 patients, 90 were aged ≥ 75 years and compared with 213 younger patients.

RESULTS

Elderly patients had fewer high-risk cytogenetic abnormalities and a longer disease history. Remarkably, teclistamab appeared more effective in this population, with 74% achieving at least a very good partial response, compared with 62% of younger patients. Median progression-free survival was 15.1 months in the elderly cohort versus 12.4 months in younger patients.

CONCLUSION

This improved efficacy did not come at the cost of increased toxicity: adverse event rates were comparable, although older patients more frequently received prophylactic measures. These findings support teclistamab as a safe and effective therapeutic option for geriatric patients with R/R MM.

TRIAL REGISTRATION: The authors have confirmed clinical trial registration is not needed for this submission.

Для цитирования: Coste A, Godet S, Manier S, Eveillard J R, Croizier C, Mariette C, Breal C, Manjra H, Touzeau C, Mohty M, Belkhir R, Bobin A, Lévêque A, Cherel B, Montes L, Orsini-Piocelle F, Frenzel L, Robu D, Chalayer E, Harel S, Vincent L, Bauschert L, Dony A, Tabrizi R, Moreau P, Hulin C, Perrot A. Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.. EJHaem. 2026. DOI: 10.1002/jha2.70233.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.